NUCB2 and early-onset autosomal dominant Alzheimer disease: Nesfatin-1 ameliorates blood-brain barrier dysfunction in Alzheimer’s disease by targeting VEGF-R1 and reducing cellular senescence in brain vascular endothelial cells